Processa Pharmaceuticals

PCSANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.549 M

$2.57 +11.74%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$13.6M

#1988 by earnings

Shares outstanding

2,660,039

Latest filing cover page

P/E ratio

0.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#435Lexaria BioscienceLEXX$8.71M
#436ExicureXCUR$8.57M
#437Processa PharmaceuticalsPCSA$8.55M
#438SoligenixSNGX$8.53M
#439Adial PharmaceuticalsADIL$8.53M

Where these numbers come from

Share counts and financials for Processa Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.